ELECTROCARDIOGRAPHIC CHANGES ASSOCIATED WITH ACUTE CEREBROVASCULAR-DISEASE - A CLINICAL REVIEW

被引:59
|
作者
DAVIS, TP
ALEXANDER, J
LESCH, M
机构
[1] HENRY FORD HOSP, DEPT MED, CARDIOVASC UNIT, DETROIT, MI 48202 USA
[2] LAKE FOREST HOSP, LAKE FOREST, IL USA
关键词
D O I
10.1016/0033-0620(93)90017-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Patients with acute vascular disorders of the CNS demonstrate an abundance of both rhythm and morphologic changes in their ECG. Of these a few will demonstrate myocardial dysfunction and or damage. The value of the ECG in evaluating and predicting which patients will have myocardial dysfunction or damage is questionable. One would assume the echocardiogram would be of more help than the ECG in identifying patients with myocardial damage; however, little data are available. The reason for the poor correlation between ECG findings and clinical correlates has not been explained to date, but it is possible to postulate a theory. There are two mechanisms that might mediate ECG changes in these patients, ie, autonomic neural stimulation from the hypothalamus or elevated circulating catecholamines. Hypothalamic stimulation may cause ECG changes without associated myocardial damage whereas elevated catecholamines may result in myocardial damage. This might explain why so many patients have ECG changes and very few have demonstrable myocardial damage in general, or ischemic damage in particular. That cardiac antiischemic therapy does not change mortality may relate to the fact that treatment has been directed towards patients with ECG changes, which in turn do not correlate with myocardial damage. Better patient selection for such therapy might rest upon demonstration of wall motion abnormalities on echocardiogram. The weakness of this strategy is that many patients with stroke have preexisting coronary disease and wall motion abnormalities and thus echo findings may only document remote infarction rather than acute ischemia. © 1993.
引用
收藏
页码:245 / 260
页数:16
相关论文
共 50 条
  • [21] CEREBROVASCULAR-DISEASE
    WHISNANT, JP
    CROWELL, RM
    PATTERSON, RH
    PEERLESS, J
    ROBERTSON, JT
    SAHS, AL
    YATSU, FM
    ARCHIVES OF NEUROLOGY, 1979, 36 : 734 - 738
  • [22] CEREBROVASCULAR-DISEASE
    HACHINSKI, V
    BAILLIERES CLINICAL NEUROLOGY, 1995, 4 (02): : R9 - R9
  • [23] CEREBROVASCULAR-DISEASE
    NORMAN, D
    BAKER, LL
    CURRENT OPINION IN NEUROLOGY AND NEUROSURGERY, 1991, 4 (06): : 837 - 842
  • [24] CEREBROVASCULAR-DISEASE
    不详
    CENTRAL AFRICAN JOURNAL OF MEDICINE, 1985, 31 (01) : 13 - 13
  • [25] CHANGES IN SERUM-LIPOPROTEINS IN CEREBROVASCULAR-DISEASE
    BRUCK, J
    FISCHER, M
    TSCHABITSCHER, H
    WIENER KLINISCHE WOCHENSCHRIFT, 1981, 93 (19) : 604 - 609
  • [26] CEREBROVASCULAR-DISEASE
    PETITO, CK
    MORGELLO, S
    CURRENT OPINION IN NEUROLOGY AND NEUROSURGERY, 1990, 3 (06): : 916 - 920
  • [27] CEREBROVASCULAR-DISEASE
    FUJISHIMA, M
    FUJII, K
    CLINICAL SCIENCE, 1994, 87 (02) : 119 - 120
  • [28] CEREBROVASCULAR-DISEASE
    MARSHALL, J
    CURRENT OPINION IN NEUROLOGY AND NEUROSURGERY, 1992, 5 (01): : 31 - 32
  • [29] CEREBROVASCULAR-DISEASE
    WARLOW, CP
    CLINICS IN HAEMATOLOGY, 1981, 10 (02): : 631 - 651
  • [30] CEREBROVASCULAR-DISEASE
    DURWARD, QJ
    NEW ZEALAND MEDICAL JOURNAL, 1984, 97 (761) : 538 - 539